雲南鍺業(002428.SZ):放棄控股子公司鑫耀公司股權轉讓優先購買權
格隆匯3月14日丨雲南鍺業(002428.SZ)公佈,2025年3月13日,雲南臨滄鑫圓鍺業股份有限公司第八屆董事會第二十四次會議審議通過《關於放棄控股子公司股權轉讓優先購買權的議案》,同意公司放棄對控股子公司雲南鑫耀半導體材料有限公司(以下簡稱“鑫耀公司”)3%股權(對應註冊資本出資額1,444.564779萬元)的優先購買權,並同意自然人惠峯先生將其持有的鑫耀公司3%的股權(對應出資額1,444.564779萬元)轉讓給廣西譽升鍺業高新技術有限公司(簡稱“廣西譽升”)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.